Oral Cannabis Metabolism and 11-Hydroxy-THC Explained

An edible and an inhaled cannabis product can contain the same amount of THC yet produce very different timing and effects.

One major reason is metabolism.

When THC is swallowed, it travels through the gastrointestinal tract and then to the liver before much of it reaches systemic circulation.

During this process, the liver converts some delta-9 THC into an active metabolite called 11-hydroxy-THC, or 11-OH-THC.

That metabolic step helps explain why oral cannabis generally has a slower onset, a later peak, and a longer duration than inhaled cannabis.

For Florida medical cannabis patients, understanding 11-hydroxy-THC can make oral dosing and timing easier to interpret.

What Is 11-Hydroxy-THC?

11-hydroxy-THC is a metabolite of delta-9 THC.

A metabolite is a compound produced when the body chemically modifies another substance.

After THC enters the liver, enzymes can add a hydroxyl group to the THC molecule.

In simplified form:

Delta-9 THC → 11-hydroxy-THC

11-hydroxy-THC remains pharmacologically active.

It can reach the brain and contribute to the psychoactive effects associated with oral THC.

What Is First-Pass Metabolism?

First-pass metabolism describes what happens when a swallowed substance travels through the digestive system and liver before reaching the broader circulation.

After an oral THC product is consumed:

1. THC moves through the stomach and intestines.
2. Some THC is absorbed through the intestinal wall.
3. Blood carries it to the liver.
4. Liver enzymes metabolize part of the THC.
5. THC and its metabolites then enter systemic circulation.

This pathway differs substantially from inhalation.

When cannabis is inhaled, THC moves from the lungs directly into the bloodstream and reaches the brain quickly, before undergoing as much initial liver metabolism.

Which Enzymes Metabolize THC?

THC metabolism involves the liver's cytochrome P450, or CYP, enzyme system.

An especially important enzyme is:

CYP2C9

Other enzymes can also contribute, including:

• CYP3A4
• CYP2C19

These enzymes help convert THC into several metabolites.

One of the most important is 11-OH-THC.

What Happens After 11-Hydroxy-THC?

11-hydroxy-THC is not the end of the pathway.

It can undergo additional oxidation and eventually become:

11-nor-9-carboxy-THC

commonly abbreviated:

THC-COOH

A simplified pathway is:

THC → 11-OH-THC → THC-COOH

These compounds behave very differently.

THC

Psychoactive.

11-OH-THC

Also psychoactive.

THC-COOH

Not considered psychoactive.

THC-COOH is one of the major metabolites commonly measured in cannabis toxicology and drug testing.

Why Oral Cannabis Feels Different

Oral THC has several pharmacokinetic characteristics that distinguish it from inhalation.

It generally has:

Slower absorption

More first-pass metabolism

Greater relative formation of 11-OH-THC

Later peak effects

Longer duration

This does not mean that 11-OH-THC alone explains every difference between edibles and inhaled cannabis.

The overall oral experience also depends on gastrointestinal absorption, formulation, dose, food intake, and individual metabolism.

Does Oral Cannabis Produce More 11-Hydroxy-THC?

Generally, yes.

11-OH-THC is produced after both oral and inhaled THC because inhaled THC eventually reaches the liver too.

However, oral administration exposes THC to substantial hepatic metabolism before it enters systemic circulation.

As a result, the amount of 11-OH-THC relative to unchanged THC is generally higher after oral administration than after inhalation.

This is an important pharmacological difference between the routes.

Is 11-Hydroxy-THC Stronger Than THC?

11-hydroxy-THC is pharmacologically active and can contribute substantially to intoxication.

Some experimental literature suggests it may produce potent psychoactive effects and cross into the brain efficiently.

However, statements such as:

“11-hydroxy-THC is exactly ten times stronger than THC”

should be treated cautiously.

Potency comparisons depend on the study design, administration method, concentration, and outcome being measured.

A more accurate patient-education statement is:

11-OH-THC is an active psychoactive metabolite that contributes to the distinctive effects of oral THC.

Why Edibles Take Longer to Work

The delay does not come from liver metabolism alone.

Before THC reaches the liver, the edible must first move through the digestive system.

Timing can be affected by:

• Gastric emptying
• Food intake
• Product formulation
• Digestive absorption
• Individual metabolism
• Dose

For many oral products, noticeable effects may take approximately 30 minutes to two hours to begin.

Peak effects can occur substantially later.

Why Oral THC Can Last Longer

Once THC and 11-OH-THC enter circulation, they distribute into tissues throughout the body.

THC is highly lipophilic, meaning it interacts readily with fatty tissues.

Oral cannabis also tends to produce slower absorption and a broader concentration-versus-time curve than inhalation.

Together, these factors can produce effects lasting several hours.

Controlled oral cannabis studies have documented subjective and performance effects lasting approximately six to eight hours after dosing, although individual experiences vary.

Why Redosing Too Soon Is Risky

Delayed onset creates a common dosing problem.

A patient takes an edible.

Forty-five minutes later, the effects still seem mild.

The patient concludes:

“It didn't work.”

Another serving is taken.

Then the original dose continues absorbing.

The second dose begins absorbing afterward.

The combined THC exposure may become much greater than intended.

This can lead to:

• Anxiety
• Dizziness
• Excessive sedation
• Confusion
• Impaired coordination
• Uncomfortable intoxication
• Increased heart rate

Understanding oral metabolism helps explain why waiting for the expected onset and peak is important.

Why Two People Can Respond Differently to the Same Dose

Oral cannabis has substantial person-to-person variability.

One patient may experience pronounced effects from a particular THC dose while another experiences much less.

Possible contributors include:

• CYP enzyme activity
• Genetics
• Age
• Liver function
• Other medications
• Food intake
• Cannabis tolerance
• Gastrointestinal absorption
• Body composition

This is another reason a standardized edible serving should not be assumed to affect every patient identically.

Genetics Can Affect THC Metabolism

CYP2C9 activity varies between individuals.

Genetic variants can reduce how efficiently this enzyme metabolizes THC.

That can change:

• THC blood concentrations
• Metabolite formation
• Duration of exposure
• Potential side effects

Routine cannabis dosing does not generally involve genetic testing, but these differences help explain why individual responses can vary considerably.

Medications May Matter Too

Because THC is metabolized through CYP enzymes, other medications that affect these enzymes could potentially alter cannabinoid exposure.

Medication interactions are especially important for patients taking multiple prescriptions.

Patients should tell their physician and pharmacist about cannabis use when discussing:

• Sedating medications
• Anticoagulants
• Seizure medications
• Psychiatric medications
• Cardiovascular drugs
• Other medications metabolized by liver enzymes

Cannabis metabolism should be considered part of the overall medication picture.

What About Sublingual Tinctures?

Tinctures are often described as sublingual products.

If cannabinoids are absorbed efficiently through tissues beneath the tongue, some of the dose may bypass initial gastrointestinal and liver processing.

However, in real-world use, some tincture is often swallowed.

That swallowed portion enters the same gastrointestinal and first-pass pathway as other oral THC.

Therefore, tinctures may produce a mixture of:

oromucosal absorption

and

oral absorption

depending on formulation and administration technique.

Fast-Acting Edibles Can Have Different Pharmacokinetics

Some edible products use specialized formulations intended to change cannabinoid dispersion or absorption.

These are often marketed as “fast acting.”

Their pharmacokinetics should not automatically be assumed to match traditional gummies, chocolates, or capsules.

Even with a faster-onset formulation, patients should follow the product instructions and physician-directed dosing plan rather than assuming that absence of an immediate effect means another dose is needed.

Green Dragon Florida Oral Product Examples

The following products illustrate different oral formulations.

They are not recommendations for a specific condition or individualized dosing instructions.

Le Remedie Drops THC Tincture — Lake City

Le Remedie Drops THC Tincture contains 100 mg THC total in a 1-fluid-ounce bottle.

The current listing identifies ten 10 mg dose units and classifies the product for the ingestion route.

This provides a useful example of a liquid THC formulation where some administered product may ultimately enter the gastrointestinal pathway and undergo first-pass metabolism.

PLUS Clementine Chews — Orange Park

PLUS Clementine Chews are currently listed at 100 mg THC total.

Traditional chews provide a straightforward example of swallowed THC.

After ingestion, THC must be absorbed through the digestive system before undergoing liver metabolism, including formation of 11-OH-THC.

Green Dragon Milk Chocolate Bar — Orange Park

Green Dragon Milk Chocolate Bar is currently listed at 100 mg THC total.

Chocolate illustrates another conventional oral format.

Its physical size does not determine cannabinoid exposure. Patients should review the labeled THC per serving and total package amount.

Product availability and formulation details may change by Green Dragon Florida location.

The Green Dragon Takeaway

Oral cannabis behaves differently from inhaled cannabis because the body processes it differently.

After swallowed THC is absorbed, the liver converts some of it into 11-hydroxy-THC, an active psychoactive metabolite.

11-OH-THC can then be metabolized further into THC-COOH, which is not psychoactive.

The simplified pathway is:

THC → 11-OH-THC → THC-COOH

This first-pass metabolism contributes to the distinctive timing of oral cannabis:

slower onset

later peak

longer duration

For medical cannabis patients, the practical lesson is not that edibles are automatically “stronger.”

It is that oral THC has different pharmacokinetics and requires different expectations around timing, titration, and redosing.

‍